tirzepatide kidneys improves kidney outcomes in T2DM with increased CV risk The benefits and risks of

That the lower, on average, body weight of women might not be the principal factor explaining the higher efficacy of the drugs in women is suggested by data indicating that women who weighed more than men on average lost more weight after liraglutide treatment (87)

In addition, multi-acting unimolecular peptides have emerged as highly promising therapeutics in obesity and T2D, typified by the GIP/GLP-1 hybrid peptide tirzepatide

[DOI] [PubMed] [Google Scholar] 74.Hayashi-Takagi A, et al

Your individual absorption rate, stomach contents, and circadian rhythm all play small but measurable roles in how your body responds to timing